GRID BATTERY METALS INC (CELL.CA) Fundamental Analysis & Valuation

TSX-V:CELL • CA3980841033

Current stock price

0.03 CAD
0 (0%)
Last:

This CELL.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CELL.CA Profitability Analysis

1.1 Basic Checks

  • CELL had negative earnings in the past year.
  • In the past year CELL has reported a negative cash flow from operations.
  • CELL had negative earnings in 4 of the past 5 years.
  • CELL had a negative operating cash flow in each of the past 5 years.
CELL.CA Yearly Net Income VS EBIT VS OCF VS FCFCELL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2M -4M

1.2 Ratios

  • The Return On Assets of CELL (-70.54%) is worse than 68.16% of its industry peers.
  • CELL has a worse Return On Equity (-71.00%) than 60.70% of its industry peers.
Industry RankSector Rank
ROA -70.54%
ROE -71%
ROIC N/A
ROA(3y)-29.33%
ROA(5y)-62.54%
ROE(3y)-29.86%
ROE(5y)-63.39%
ROIC(3y)N/A
ROIC(5y)N/A
CELL.CA Yearly ROA, ROE, ROICCELL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CELL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CELL.CA Yearly Profit, Operating, Gross MarginsCELL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CELL.CA Health Analysis

2.1 Basic Checks

  • CELL has more shares outstanding than it did 1 year ago.
  • CELL has more shares outstanding than it did 5 years ago.
  • CELL has a better debt/assets ratio than last year.
CELL.CA Yearly Shares OutstandingCELL.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CELL.CA Yearly Total Debt VS Total AssetsCELL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

  • An Altman-Z score of 133.04 indicates that CELL is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 133.04, CELL belongs to the best of the industry, outperforming 92.91% of the companies in the same industry.
  • There is no outstanding debt for CELL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 133.04
ROIC/WACCN/A
WACCN/A
CELL.CA Yearly LT Debt VS Equity VS FCFCELL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

  • A Current Ratio of 27.58 indicates that CELL has no problem at all paying its short term obligations.
  • CELL's Current ratio of 27.58 is amongst the best of the industry. CELL outperforms 94.53% of its industry peers.
  • A Quick Ratio of 27.58 indicates that CELL has no problem at all paying its short term obligations.
  • CELL has a Quick ratio of 27.58. This is amongst the best in the industry. CELL outperforms 94.53% of its industry peers.
Industry RankSector Rank
Current Ratio 27.58
Quick Ratio 27.58
CELL.CA Yearly Current Assets VS Current LiabilitesCELL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CELL.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 8.86% over the past year.
EPS 1Y (TTM)8.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CELL.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • CELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CELL.CA Price Earnings VS Forward Price EarningsCELL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CELL.CA Per share dataCELL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CELL.CA Dividend Analysis

5.1 Amount

  • CELL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CELL.CA Fundamentals: All Metrics, Ratios and Statistics

GRID BATTERY METALS INC

TSX-V:CELL (3/19/2026, 7:00:00 PM)

0.03

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-20
Earnings (Next)05-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.63%
Ins Owner ChangeN/A
Market Cap5.80M
Revenue(TTM)N/A
Net Income(TTM)-2.74M
Analysts80
Price Target0.19 (533.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.51
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -70.54%
ROE -71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.33%
ROA(5y)-62.54%
ROE(3y)-29.86%
ROE(5y)-63.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1976.4%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 27.58
Quick Ratio 27.58
Altman-Z 133.04
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5571.27%
Cap/Depr(5y)4362.76%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.47%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29%
OCF growth 3YN/A
OCF growth 5YN/A

GRID BATTERY METALS INC / CELL.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GRID BATTERY METALS INC (CELL.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CELL.CA.


What is the valuation status for CELL stock?

ChartMill assigns a valuation rating of 0 / 10 to GRID BATTERY METALS INC (CELL.CA). This can be considered as Overvalued.


What is the profitability of CELL stock?

GRID BATTERY METALS INC (CELL.CA) has a profitability rating of 0 / 10.